MRK

Merck & Co., Inc.NYSEHealthcare

$120.87+0.02%OpenMarket Cap: $298.84B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-30	RBC Capital	—	Outperform	—
2026-03-20	Citigroup	—	Neutral	—
2026-03-12	Wells Fargo	—	Overweight	—
2026-02-09	Freedom Broker	—	Hold	—
2026-02-06	Guggenheim	—	Buy	—
2026-02-04	Wells Fargo	—	Overweight	—
2026-02-04	Cantor Fitzgerald	—	Neutral	—
2026-02-04	Citigroup	—	Neutral	—
2026-01-20	TD Cowen	—	Hold	—
2026-01-08	Wolfe Research	—	Outperform	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$9.69	$70.23B	13
Sun Dec 31	$10.75	$74.93B	7
Mon Dec 31	$10.36	$74.56B	2
Tue Dec 31	$10.16	$74.14B	5